Connect with us

Technology

JuveXO® Unveils Verified Exosome Images, Setting a New Standard in Transparency and Scientific Proof in Cosmetics

Published

on

MIAMI, April 22, 2025 /PRNewswire/ — The scientific team at JuveXO®, one of the most advanced exosome-based solutions available today, is thrilled to announce the first images of exosomes – an incredible achievement that positions JuveXO® at the forefront of biocosmetic discovery. Born from decades of research and innovation by Chief Development & Science Officer (CDSO) Rafael Gonzalez, PhD, a leading figure in cell therapy research, and the scientists behind JuveXO® have fully characterized their exosomes and gone above and beyond to show off their superior exosome product. JuveXO boasts billions of exosomes in each of its vials as well as naturally occurring High Molecular Weight Hyaluronic Acid, Collagen I and III, Glutathione, Biotin, Peptides, and Growth Factors. JuveXO is used topically for hair and skin rejuvenation post aesthetic treatments such as microneedling, RF (radiofrequency) laser, CO2 laser, hair restoration procedures, and chemical peels, enhancing recovery and optimizing results. https://juvexo.com/blogs/articles/breaking-ground-juvexos-first-image-of-an-exosome-a-new-era-in-scientific-visualization

JuveXO® releases verified exosome images—setting a new benchmark for scientific proof in aesthetics.

But first, what are exosomes? Exosomes are small extracellular vesicles that play a pivotal role in intercellular communication, serving as vehicles for the transport of various biomolecules such as proteins, lipids, and nucleic acids between cells. Exosome technology has garnered significant attention in recent years due to their multifaceted functions and profound implications. JuveXO® is the first biocosmetic company to image exosomes both in frozen vials and following lyophilization using advanced electron microscopy techniques, the correct approach to visualizing an exosome and demonstrating its presence. The ability to visualize exosomes with such precision gives JuveXO® a significant competitive advantage over other players in the biocosmetic sector.

With research on optimal biocosmetic formulations stemming back to 2014, JuveXO® stands out as a distinctive scientific leader in the rapidly evolving field of biocosmetics space. JuveXO®’s umbilical cord lining stem cells (ULSCs) are superior to a standard MSC, were specifically researched and designed for the biocosmetic space—offering optimal results for the skin. 

Chief Development & Science Officer (CDSO) Rafael Gonzalez, PhD of JuveXO® says, “It’s a groundbreaking time for all of us at JuveXO® who have dedicated so much research, time and resources perfecting our product. The ability to visualize exosomes with such precision gives JuveXO® a significant competitive advantage over other players in the biocosmetic and aesthetic sectors. The imaging technology that JuveXO® employs represents a significant leap forward in the field of aesthetics, enabling practitioners to see that the product truly does contain exosomes. This helps them trust the products they are providing to patients.”

While the ability to visualize exosomes decades ago marked a significant breakthrough in biomedical research for new scientific innovations, many exosome-derived products lacked rigorous validation until recently. Adopting advanced imaging methods has allowed researchers at JuveXO® to deepen their understanding of the exosome. Today, as numerous brands enter the market with claims of including exosomes in their products, the leaders at Congela Biocosmetics, the distributor of JuveXO, are raising the bar for industry transparency. By conclusively proving the presence of exosomes in our products, we invite others to meet this new standard of verification. Our message to the industry is straightforward: “We’ve shown you ours, now you show us yours.”

To prove their presence and integrity in products, JuveXO® has embraced the standards set by the International Society for Extracellular Vesicles (ISEV), which recommends specific techniques for confirming exosome presence, such as nanoparticle tracking analysis, tunable resistive pulse sensing, and electron microscopy amongst other marker expressions that need to be present. Electron microscopy, specifically, allows for the direct observation of exosomes, showcasing their size, shape, and the integrity of their bilipid layers, which are crucial for their functionality.

Utilizing state-of-the-art equipment and methodologies, researchers can accurately observe exosomes on a nanoscale level, pinpointing their presence and concentration in biological samples that lead to deeper scientific insights. By adhering to these ISEV-endorsed techniques and especially employing electron microscopy, JuveXO® not only substantiates the presence of genuine exosomes in their products but also ensures they remain intact and functional from production to delivery. This adherence to the highest scientific standards establishes a new benchmark in product transparency and trust, pioneering a standard that should define the future of regenerative medicine and cosmetic industries alike.

ABOUT JuveXO®
JuveXO® is a high-quality umbilical cord lining stem cell (ULSCs) product that is superior to standard MSC-derived secretome products. We have a patent-pending technology that enables control of the protein type released by ULSCs. With more than ten years of research, JuveXO® has been specially designed to contain high amounts of naturally occurring Types I and III Collagen, Biotin, Gluthathione, Chondroitin Sulfate, Growth Factors, and High-Molecular-Weight Hyaluronic Acid, making JuveXO® the leader in cosmetic use. Our premium serum line is produced from vigorously tested, postnatal ULSCs and is pre-COVID and cell-free. JuveXO® offers a comprehensive exosome portfolio, including:

JuveXO® Pro – A multi-dose vial designed for professional aesthetic skincare treatments that boasts 50 billion exosomes per mL.JuveXO® Pro H – Developed specifically for scalp and hair restoration applications with 50 billion exosomes per mL.JuveXO® Lyo – A lyophilized formula with 25 billion exosomes per vial that can be reconstituted to service up to 5 patients, offering greater flexibility and convenience.

JuveXO products are developed in an FDA-registered laboratory which follows good manufacturing practices, ensuring the highest standards of quality, safety, and compliance. Our commitment to excellence is underscored by adherence to rigorous regulatory standards and ethical practices, providing practitioners and consumers with trusted and effective biocosmetic solutions. To find a provider near you, visit JuveXO.com. If you are a physician interested in becoming a provider, visit https://juvexo.com/account/register.

For more information or interviews requests, please contact:
Creative Media Marketing | juvexo@cmmpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/juvexo-unveils-verified-exosome-images-setting-a-new-standard-in-transparency-and-scientific-proof-in-cosmetics-302433763.html

SOURCE JuveXO®

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Asian American Engineer of the Year Award and Conference Announces First Phase of 2025-2026 Awardees

Published

on

By

SANTA CLARA, Calif., May 1, 2026 /PRNewswire/ — The Asian American Engineer of the Year Award (AAEOY) Executive Committee announces the AAEOY 2025-2026 first phase awardees as follows:

Distinguished Lifetime Achievement Award

Mr. Lip-Bu Tan, CEO, Intel Corporation

Distinguished Leadership in Science and Technology Award

Dr. Arun Majumdar, Dean of the Stanford Doerr School of Sustainability, Stanford University

Executive of the Year Award

Dr. Xiaodong Che, Chief Technology Officer, Western DigitalDr. Sam Heidari, CEO, LumotiveDr. Jungwon Lee, Corporate Executive Vice President, Samsung ElectronicsDr. Liu Ren, Vice President & Chief Scientist, Bosch ResearchMr. Brandon Wang, Vice President, Synopsys

Engineer of the Year Award

Ms. Vivian Ye, Principal Member of Technical Staff, AT&T

Most Promising Engineer of the Year Award

Mr. Max Fang, Director of Architecture, AmbarellaMr. Johnny Ho, CSO & Co-founder, Perplexity AI

The AAEOY Award has been presented annually since 2002 as a cornerstone of the National Engineers Week program, honoring distinguished Asian American professionals across academia, public service, and industry. Since its inception, the AAEOY has recognized over 300 honorees — including nine Nobel Laureates, pioneering scholars, prominent corporate executives, and an astronaut — serving as a beacon of inspiration for the global STEM community. After a series of impactful ceremonies nationwide, the 2025-2026 AAEOY Award and Conference returns to the heart of innovation in Silicon Valley at the Santa Clara Convention Center on September 18-19, 2026.

For more information regarding the AAEOY program, awardees, and event registration, please visit www.aaeoy.org.

The Chinese Institute of Engineers in USA (CIE-USA), founded in 1917, is a nonprofit professional organization that promotes science, technology, engineering, and mathematics (STEM); supports professional advancement and leadership development; and recognizes the achievements of Asian American professionals through flagship programs such as the Asian American Engineer of the Year (AAEOY) Awards. One of the oldest and most prestigious Chinese American engineering associations in the United States, CIE-USA has seven regional chapters nationwide and hosts events throughout the year.

View original content to download multimedia:https://www.prnewswire.com/news-releases/asian-american-engineer-of-the-year-award-and-conference-announces-first-phase-of-2025-2026-awardees-302760569.html

SOURCE AAEOY

Continue Reading

Technology

Larry Kellerman, Fermi’s Chief Power Officer and Architect of Its 17 GW Energy Infrastructure, Accepts Board Nomination

Published

on

By

DALLAS, May 1, 2026 /PRNewswire/ — Toby Neugebauer, co-founder and largest shareholder of Fermi America (NASDAQ & LSE: FRMI), today announced that he has nominated Larry Kellerman to join the Fermi Board of Directors. Kellerman, who serves as Chief Power Officer at Fermi America, is the architect of the Company’s 17-gigawatt powered data center campus in Amarillo, Texas — the largest private energy grid in America.

Kellerman is co-founder and Managing Partner of Twenty First Century Utilities and brings more than four decades of power industry and finance expertise to the role. His career spans senior leadership positions at Goldman Sachs, El Paso Corporation, and I Squared Capital. Kellerman said he was honored by the nomination and would be pleased to serve if approved by the Board.

“I appreciate everything that Toby has manifested in Fermi and know that no other human could have created the enterprise and its many thoughtfully interconnected elements as quickly, as effectively, and in as value-accretive a manner as Toby’s leadership has been able to deliver.”
— Larry Kellerman, Chief Power Officer and Board Nominee, Fermi America

For Neugebauer, the choice was crystal clear. Kellerman, who has worked alongside Neugebauer since the earliest days of Project Matador knows Fermi’s power story better than anyone.

“When I came up with the idea of Project Matador, I knew that Larry Kellerman was the one person I needed to convert a really great idea into a really great reality. His knowledge of power and the future of powering data centers is unmatched. Larry is uniquely qualified to steward Fermi as a Board member, and I couldn’t be more pleased with his willingness to serve.”
— Toby Neugebauer, Co-Founder, Fermi America

View original content:https://www.prnewswire.com/news-releases/larry-kellerman-fermis-chief-power-officer-and-architect-of-its-17-gw-energy-infrastructure-accepts-board-nomination-302760575.html

SOURCE Toby Neugebauer

Continue Reading

Technology

EAST SIDE GAMES GROUP ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OF UNITS TO RAISE UP TO $3.5 MILLION

Published

on

By

VANCOUVER, BC, May 1, 2026 /CNW/ – East Side Games Group (TSX: EAGR) (OTC: EAGRF) (the “Company”), Canada’s leading free-to-play mobile game group, announces a non-brokered private placement of 31,818,182  units (a “Unit”) at $0.11 per Unit (the “Unit Price”), for total gross proceeds of up to $3.5 million. 

Each Unit will be comprised of one common share and one full whole warrant (a “Warrant”).  Each whole Warrant will be exercisable at $0.14 per share (the “Exercise Price”) for a period of three years from issuance. The Warrants will be subject to standard anti-dilution adjustments.

The private placement will be offered in reliance on prospectus exemptions, and any securities sold will be subject to a four month statutory hold period.  The private placement is not anticipated to have any material impact on the control of the Company, nor is it anticipated that any new control persons would be created as a result of the private placement.

It is anticipated that Derek Lew, a director of the Company, will participate in the private placement for an amount of $1.0 million for 9,090,909 Units. As at the date of this news release, Mr. Lew holds 1,667,244 common shares of the Company (2.17%). If the private placement is completed as anticipated, Mr. Lew will hold 10,758,153 common shares (representing 9.89% of the common shares anticipated to be outstanding upon completion of the private placement on a partially diluted basis), 9,090,909 Warrants and 250,000 incentive stock options. Upon exercise of his Warrants, Mr. Lew would own 19,849,062 common shares representing 16.84% of the then issued and outstanding common shares assuming no other share issuances.

The TSX Company Manual requires shareholder approval be obtained  for private placements if the maximum number of common shares issuable under the private placement represents an amount that is more than 25% of the total outstanding common shares as at the date of the press release (pursuant to Section 607(g)). Disinterested shareholder approval must be obtained (excluding those shareholders participating in this private placement and their associates and affiliates) if the number of common shares issued and issuable to insiders under a private placement exceeds 10% of the Company’s issued and outstanding common shares as of the date hereof (pursuant to Section 607(g)(ii)).

As: (a) the private placement is for up to 31,818,182 Units (being equivalent to 41.35% of the Company’s outstanding shares as at the date of this press release), (b) Mr. Lew’s subscription for 9,090,909 Units represents an amount that is equivalent to 11.81% of the Company’s outstanding shares as at the date of this press release, and (c) the Warrants comprising the Units have an exercise price of $0.14 per share (and the five day VWAP is $0.144 per share), the Company has obtained written consent from Jason Bailey, the Company’s CEO and a director, in support of the private placement in accordance with Section 604(d) of the TSX Company Manual.  Mr. Bailey holds more than 50% of the Company’s outstanding shares as at the date of this press release.

The net proceeds from the private placement will be used to repay indebtedness owing to the Royal Bank of Canada (RBC) and for operating expenses and general working capital. Mr. Bailey commented, “With this funding in place, we are on solid footing to continue our disciplined approach to completing the business’s turnaround. With our core portfolio of well performing titles, we have a solid foundation to rebuild upon. We feel we have a strong runway, pipeline and team to execute toward a positive 2026,” [and] “I’d like to thank our existing shareholders for their support and guidance through a difficult 2025 and look forward to achieving the results that will allow this Company, our capital markets strategy and employees to reach its potential.”

The Company’s board of directors considers the private placement to be in the best interests of its shareholders, after having taken into account other alternative forms of financing.  In the course of its review, the Company considered other replacement debt financing, the Company’s ongoing cashflow from operations, as well as ongoing operating expenses, one-off necessary expenditures and the Company’s debt load, within the larger context of the analysis detailed in its press release dated March 31, 2026 as to the re-orienting of the Company’s overall business strategy. 

The Company anticipates that the private placement will close on or before May 8, 2026, subject to acceptance by the TSX.

The Company reserves the right to pay finder’s fees in the form of common shares (in lieu of cash fees) and broker warrants to arm’s length finders in connection with the private placement to arm’s length parties, in accordance with TSX policies. No finder’s fee will be paid to any non-arm’s length parties, nor with respect to subscriptions from non-arm’s length parties.  A maximum number of 1,363,636 common shares (to be issued at $0.11 per share for a total value of $150,000) and a maximum number of 1,254,545 broker warrants will be issuable, assuming the private placement is fully subscribed.  Each broker warrant will entitle the holder to acquire one common share at $0.14 per common share (the “Broker Warrant Exercise Price”) for a period of three years form issuance.  

The maximum number of securities issuable under the private placement is 66,254,545 common shares, comprising 31,818,182 common shares comprising the Units, 31,818,182 common shares issuable upon exercise of the Warrants, 1,363,636 common shares to be issued as finder’s fees, and 1,254,545 common shares issuable upon exercise of the broker warrants, which represents an amount equivalent to 86.10% of the total outstanding common shares as at the date of this press release on a non-diluted basis, without taking into effect the private placement itself, or approximately 46.27% of the Company’s total issued and outstanding common shares following completion of the private placement (being 143,200,825 shares anticipated to be outstanding on a partially diluted basis, assuming the private placement is fully subscribed, full issuance of the finder’s fee shares and full exercise of the Warrants and broker warrants). The Unit Price represents a 22% discount to the Company’s five-day volume-weighted trading price of its common shares on the TSX as at the time of submitting the Company’s application to TSX (the “Market Price”). Market Price and the Exercise Price and the Broker Warrant Exercise Price represent a 2.47% discount to the Market Price.

The total number of common shares expected to be issued to insider (Mr. Lew) under the private placement is 18,181,818 (consisting of 9,090,909 common shares and 9,090,909 common shares issuable upon full exercise of Warrants), representing 23.63% of the total outstanding common shares as at the date of this press release on a non-diluted basis, without taking into effect the private placement itself, or 12.70% of the Company’s total issued and outstanding common shares following completion of the private placement (being 143,200,825 shares anticipated to be outstanding on a partially diluted basis, assuming the private placement is fully subscribed, full issuance of the finder’s fee shares and full exercise of the Warrants and the broker warrants).

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States.  The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered or sold within the United states or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration is available.

ABOUT EAST SIDE GAMES GROUP

ESGG is a leader in free-to-play mobile gaming, thrilling players with unforgettable experiences that spark lifelong fandom. Fueled by an entrepreneurial spirit, we are driven by creativity, flawless execution, and a laser-focused strategy. We develop and publish both original and licensed IP titles, license our cutting-edge GameKit(s) platforms, and strategically acquire studios or games to expand our family.

Headquartered in Vancouver with around 100 talent-dense team members, we operate over a dozen titles under East Side Games (“ESG”) and LDRLY (Technologies) Inc. (“LDRLY”). Together, we’re crafting, launching, and publishing mobile games across our own studios and an extended Game Kit partner network-reaching players on iOS and Android worldwide.

We power our success through in-app purchases (“IAP”) — offering exclusive, game-enhancing virtual items — and in-game advertising. To keep growing, we focus on captivating audiences, keeping them engaged, and unlocking exciting new ways to monetize. We’ll drive this momentum by launching bold new titles, enriching our current lineup, innovating discovery, expanding into fresh markets, and exploring new distribution platforms.

Additional information about the Company continues to be available under its legal name, East Side Games Group Inc., at www.sedarplus.ca.

Forward-looking Information

Certain statements in this news release constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as “expects,” “anticipates,” “plans,” “intends,” “believes,” “estimates,” “projects,” “may,” “will,” “would,” “could,” “should,” and similar expressions. Forward-looking statements in this news release include, without limitation, statements regarding the proposed private placement.

Forward-looking statements are based on management’s current expectations, estimates, projections and assumptions. Such forward-looking statements are subject to significant risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied by such statements, including, without limitation, risks relating to the Company’s ability to complete the proposed private placement as described, and relating to general economic, market and industry conditions. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

SOURCE East Side Games Group Inc.

Continue Reading

Trending